{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T06:29:06Z","timestamp":1776407346413,"version":"3.51.2"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T00:00:00Z","timestamp":1695427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T00:00:00Z","timestamp":1695427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s10067-023-06724-3","type":"journal-article","created":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T07:01:41Z","timestamp":1695452501000},"page":"3251-3255","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cause analysis of conversion to biologics in spondyloarthritis patients with poor response to conventional treatment"],"prefix":"10.1007","volume":"42","author":[{"given":"Jun","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feifeng","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongmei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6406-9563","authenticated-orcid":false,"given":"Lin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,23]]},"reference":[{"issue":"10","key":"6724_CR1","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1002\/art.41042","volume":"71","author":"MM Ward","year":"2019","unstructured":"Ward MM, Deodhar A, Gensler LS, Dubreuil M, Yu D, Khan MA et al (2019) 2019 Update of the American College of Rheumatology\/Spondylitis Association of America\/Spondyloarthritis Research and treatment network recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis Rheum 71(10):1599\u20131613","journal-title":"Arthritis Rheum"},{"issue":"6","key":"6724_CR2","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1007\/s10067-018-4061-y","volume":"37","author":"A Schramm-Luc","year":"2018","unstructured":"Schramm-Luc A, Schramm J, Siedlinski M, Guzik TJ, Batko B (2018) Age determines response to anti-TNFalpha treatment in patients with ankylosing spondylitis and is related to TNFalpha-producing CD8 cells. Clin Rheumatol 37(6):1597\u20131604","journal-title":"Clin Rheumatol"},{"issue":"6","key":"6724_CR3","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1136\/ard.2003.016386","volume":"63","author":"M Rudwaleit","year":"2004","unstructured":"Rudwaleit M, Listing J, Brandt J, Braun J, Sieper J (2004) Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor alpha blockers in ankylosing spondylitis. Ann Rheum Dis 63(6):665\u2013670","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"6724_CR4","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1136\/ard.2007.075754","volume":"67","author":"N Zeboulon","year":"2008","unstructured":"Zeboulon N, Dougados M, Gossec L (2008) Prevalence and characteristics of uveitis in the spondyloarthropathies: a systematic literature review. Ann Rheum Dis 67(7):955\u2013959","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"6724_CR5","first-page":"1","volume":"18","author":"MA Khan","year":"1992","unstructured":"Khan MA (1992) Spondyloarthropathies. Rheum Dis Clin N Am 18(1):1\u2013276","journal-title":"Spondyloarthropathies. Rheum Dis Clin N Am"},{"issue":"2","key":"6724_CR6","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10792-011-9430-3","volume":"31","author":"P Neri","year":"2011","unstructured":"Neri P, Zucchi M, Allegri P, Lettieri M, Mariotti C, Giovannini A (2011) Adalimumab (Humira): a promising monoclonal anti-tumor necrosis factor alpha in ophthalmology. Int Ophthalmol 31(2):165\u2013173","journal-title":"Int Ophthalmol"},{"issue":"5","key":"6724_CR7","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1136\/ard.2008.092585","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, Rodevand E, Holck P, Vanhoof J, Kron M, Kary S et al (2009) Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study. Ann Rheum Dis 68(5):696\u2013701","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"6724_CR8","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrrheum.2016.178","volume":"13","author":"BN Cronstein","year":"2017","unstructured":"Cronstein BN, Sitkovsky M (2017) Adenosine and adenosine receptors in the pathogenesis and treatment of rheumatic diseases. Nat Rev Rheumatol 13(1):41\u201351","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"6724_CR9","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0950-3579(89)80021-4","volume":"3","author":"KD Katz","year":"1989","unstructured":"Katz KD, Hollander D (1989) Intestinal mucosal permeability and rheumatological diseases. Baillieres Clin Rheumatol 3(2):271\u2013284","journal-title":"Baillieres Clin Rheumatol"},{"issue":"5","key":"6724_CR10","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1093\/rheumatology\/26.5.334","volume":"26","author":"VC Neumann","year":"1987","unstructured":"Neumann VC, Shinebaum R, Cooke EM, Wright V (1987) Effects of sulphasalazine on faecal flora in patients with rheumatoid arthritis: a comparison with penicillamine. Br J Rheumatol 26(5):334\u2013337","journal-title":"Br J Rheumatol"},{"issue":"8","key":"6724_CR11","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1002\/art.1780370806","volume":"37","author":"J Hayllar","year":"1994","unstructured":"Hayllar J, Smith T, Macpherson A, Price AB, Gumpel M, Bjarnason I (1994) Nonsteroidal antiinflammatory drug-induced small intestinal inflammation and blood loss. Effects of sulfasalazine and other disease-modifying antirheumatic drugs. Arthritis Rheum 37(8):1146\u20131150","journal-title":"Arthritis Rheum"},{"issue":"5","key":"6724_CR12","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00296-016-3452-0","volume":"36","author":"N Damjanov","year":"2016","unstructured":"Damjanov N, Shehhi WA, Huang F, Kotak S, Burgos-Vargas R, Shirazy K et al (2016) Assessment of clinical efficacy and safety in a randomized double-blind study of etanercept and sulfasalazine in patients with ankylosing spondylitis from Eastern\/Central Europe, Latin America, and Asia. Rheumatol Int 36(5):643\u2013651","journal-title":"Rheumatol Int"},{"issue":"9","key":"6724_CR13","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1136\/ard.2006.052878","volume":"65","author":"J Braun","year":"2006","unstructured":"Braun J, Zochling J, Baraliakos X, Alten R, Burmester G, Grasedyck K et al (2006) Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trial. Ann Rheum Dis 65(9):1147\u20131153","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"6724_CR14","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/1756-185X.13124","volume":"21","author":"S Khanna Sharma","year":"2018","unstructured":"Khanna Sharma S, Kadiyala V, Naidu G, Dhir V (2018) A randomized controlled trial to study the efficacy of sulfasalazine for axial disease in ankylosing spondylitis. Int J Rheum Dis 21(1):308\u2013314","journal-title":"Int J Rheum Dis"},{"issue":"4","key":"6724_CR15","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1136\/ard.2009.114397","volume":"69","author":"PT Yang","year":"2010","unstructured":"Yang PT, Xiao WG, Qin L, Zhao LJ, He LM, Ito M (2010) A pilot study on changes of macrophage colony stimulating factor and transforming growth factor beta1 in male patients with ankylosing spondylitis taking thalidomide. Ann Rheum Dis 69(4):781\u2013782","journal-title":"Ann Rheum Dis"},{"issue":"6 Suppl 28","key":"6724_CR16","first-page":"S158","volume":"20","author":"F Huang","year":"2002","unstructured":"Huang F, Wei JC, Breban M (2002) Thalidomide in ankylosing spondylitis. Clin Exp Rheumatol 20(6 Suppl 28):S158\u2013S161","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"6724_CR17","first-page":"2627","volume":"30","author":"JC Wei","year":"2003","unstructured":"Wei JC, Chan TW, Lin HS, Huang F, Chou CT (2003) Thalidomide for severe refractory ankylosing spondylitis: a 6-month open-label trial. J Rheumatol 30(12):2627\u20132631","journal-title":"J Rheumatol"},{"issue":"3","key":"6724_CR18","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S0889-857X(03)00028-0","volume":"29","author":"JC Davis Jr","year":"2003","unstructured":"Davis JC Jr, Huang F, Maksymowych W (2003) New therapies for ankylosing spondylitis: etanercept, thalidomide, and pamidronate. Rheum Dis Clin N Am 29(3):481\u2013494 viii","journal-title":"Rheum Dis Clin N Am"},{"issue":"3","key":"6724_CR19","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.21037\/apm-19-409","volume":"10","author":"S Zhang","year":"2021","unstructured":"Zhang S, Chen Z, Wu Y, Lin D, He J, Liu J et al (2021) Efficacy and safety of thalidomide on psychological symptoms and sleep disturbances in the patient with refractory ankylosing spondylitis. Ann Palliat Med 10(3):2512\u20132519","journal-title":"Ann Palliat Med"},{"issue":"8","key":"6724_CR20","first-page":"667","volume":"49","author":"J Zhu","year":"2010","unstructured":"Zhu J, Huang F, Zhang JL (2010) The efficacy and safety of long-term thalidomide in the treatment of ankylosing spondylitis. Zhonghua Nei Ke Za Zhi 49(8):667\u2013670","journal-title":"Zhonghua Nei Ke Za Zhi"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06724-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-023-06724-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06724-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T18:04:15Z","timestamp":1699725855000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-023-06724-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,23]]},"references-count":20,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["6724"],"URL":"https:\/\/doi.org\/10.1007\/s10067-023-06724-3","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,23]]},"assertion":[{"value":"6 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}